Upstate Active Clinical Trials
Study Title:
ACNS1821 - A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)What is the purpose of the study? (in Layman's terms, please describe the study)
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)Upstate Institutional Review Board (IRB) Number:
1921131Study/Protocol ID:
ACNS1821Study Phase:
I/IIPatient Age Group:
ChildrenPrincipal Investigator:
Melanie A ComitoWho is eligible?
≥ 12 months and ≤ 21 years of ageWhat is involved if I participate?
- How long is the study?
N/A - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
N/A
Where will the study take place?
Upstate Pediatric Cancer CenterOther Information:
N/AWho can I contact for more information?
Name: Suzanne M Majewski
Phone: 315-464-7232
Email: [email protected]